Celularity (CELUW) EBIT (2019 - 2025)
Celularity (CELUW) reported EBIT of $20.0 million for Q4 2025, up 315.32% year-over-year from $4.8 million in Q4 2024, and up 254.9% quarter-over-quarter from -$12.9 million in Q3 2025.
Celularity (CELUW) EBIT (2019 - 2025) Analysis & Trends
Celularity (CELUW) has 7 years of EBIT data on file, last reported at $20.0 million in Q4 2025.
- EBIT for Q4 2025 came in at $20.0 million, up 315.32% year-over-year; the trailing twelve-month figure through Dec 2025 was -$19.3 million (up 49.77% YoY), and the FY2025 annual result was -$19.3 million, up 49.77% from the prior year.
- EBIT climbed to $20.0 million in Q4 2025 per CELUW's latest filing, from -$12.9 million in the prior quarter.
- Over five years, EBIT peaked at $20.0 million in Q4 2025 and troughed at -$99.3 million in Q3 2023.
- A 5-year average of -$19.2 million and a median of -$11.0 million in 2024 frame the typical range for EBIT.
- On a YoY basis, EBIT climbed as much as 326.76% in 2021 and fell as far as 29007.3% in 2021.
- A 5-year view of EBIT shows it stood at -$15.0 million in 2021, then soared by 216.95% to $17.5 million in 2022, then declined by 23.85% to $13.3 million in 2023, then tumbled by 169.7% to -$9.3 million in 2024, then surged by 315.32% to $20.0 million in 2025.
- Business Quant data shows CELUW's EBIT at $20.0 million in Q4 2025, -$12.9 million in Q3 2025, and -$15.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.51 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Celularity | - | - | -3.27 Mn | 19.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 19.98 Mn |
| Sep 30, 2025 | -12.90 Mn |
| Jun 30, 2025 | -15.86 Mn |
| Mar 31, 2025 | -10.49 Mn |
| Dec 31, 2024 | -9.28 Mn |
| Sep 30, 2024 | -11.53 Mn |
| Jun 30, 2024 | -10.18 Mn |
| Mar 31, 2024 | -7.38 Mn |
| Dec 31, 2023 | 13.32 Mn |
| Sep 30, 2023 | -99.26 Mn |
| Jun 30, 2023 | -42.48 Mn |
| Mar 31, 2023 | -63.87 Mn |
| Dec 31, 2022 | 17.49 Mn |
| Sep 30, 2022 | -5.65 Mn |
| Jun 30, 2022 | 4.18 Mn |
| Mar 31, 2022 | -41.61 Mn |
| Dec 31, 2021 | -14.95 Mn |
| Sep 30, 2021 | 10.90 Mn |
| Jun 30, 2021 | -60.61 Mn |
| Mar 31, 2021 | -44.40 Mn |